Laurie Stelzer, Chief Financial Officer at Mirati Therapeutics, Inc. (MRTX), sold 9,294 shares at $37.06 ($344K) on 2023-06-02, disclosed to the SEC on 2023-06-02.
Open-market sale of $344k MRTX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.06 | 4,647 | $172K | 50.0% |
| 2 | $37.06 | 4,647 | $172K | 50.0% |
| Total | $37.06 avg | 9,294 | $344K | 100% |